DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Filibuvir is an investigational drug.
There have been 4 clinical trials for Filibuvir. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, Chronic, and Hepatitis C, Chronic. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for Filibuvir
|Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance||Pfizer||Phase 1|
|Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)||Pfizer||Phase 1|
|A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers||Pfizer||Phase 1|